Details for New Drug Application (NDA): 215186
✉ Email this page to a colleague
NDA 215186 describes BETAMETHASONE DIPROPIONATE, which is a drug marketed by Anda Repository, Fougera Pharms, Glenmark Pharms Inc, Padagis Israel, Taro, Actavis Mid Atlantic, Cosette, Perrigo New York, Pharmaderm, Teva, Zydus Pharms, Encube, Hikma, Alpharma Us Pharms, Fougera Pharms Inc, Padagis Us, Shree Hari Intl, Aurobindo Pharma Ltd, Lupin Ltd, Tasman Pharma, and Zydus Lifesciences, and is included in forty-seven NDAs. It is available from twenty-two suppliers. Additional details are available on the BETAMETHASONE DIPROPIONATE profile page.
The generic ingredient in BETAMETHASONE DIPROPIONATE is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.
The generic ingredient in BETAMETHASONE DIPROPIONATE is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.
Summary for 215186
| Tradename: | BETAMETHASONE DIPROPIONATE |
| Applicant: | Tasman Pharma |
| Ingredient: | betamethasone dipropionate |
| Patents: | 0 |
Pharmacology for NDA: 215186
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 215186
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | OINTMENT;TOPICAL | 215186 | ANDA | TruPharma LLC | 52817-824 | 52817-824-15 | 1 TUBE in 1 CARTON (52817-824-15) / 15 g in 1 TUBE |
| BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | OINTMENT;TOPICAL | 215186 | ANDA | TruPharma LLC | 52817-824 | 52817-824-45 | 1 TUBE in 1 CARTON (52817-824-45) / 45 g in 1 TUBE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;TOPICAL | Strength | EQ 0.05% BASE | ||||
| Approval Date: | Feb 18, 2022 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
